Novo Nordisk Pharmaceuticals Pty Ltd (Novo Nordisk) is pleased to provide community pharmacies with the opportunity to participate in the NovoPen® 6 Pharmacy Program. Novo Nordisk has engaged PharmaPrograms to manage the NovoPen® 6 Pharmacy Program on its behalf. The program is designed to support diabetes patients who have been prescribed a Novo Nordisk insulin cartridge (Penfill®), by ensuring they have immediate access to the NovoPen® 6 device as well as access to device education. NovoPen® 6 is a new, smart insulin pen that automatically records insulin dosing information about each injection.